Genomic research is a major driver that has benefited the in vitro diagnostics (IVD) industry. But more recently, the industry is responding to several widespread developments, which have triggered innovations and expansion in IVD technologies. Industry trends are grounded in rapid disease identification, ease of use and personalized care and the advanced use of analytics. These trends are pushing IVD researchers to expand the current base of IVD technologies as well as to pursue work on developing new ones. The technologies that are most heavily influenced by these trends are point-of-care (POC), microfluidics, liquid biopsy, molecular diagnostics, and artificial intelligence (AI) and the Internet of Things (IoT) used in conjunction with IVD. Besides, the IVD detection platform is increasingly diversified and the detection method is basically transitioning to semi-quantitative and quantitative direction.
In 2017, the United Nations estimated that 962 million people or 13% of the world's population are aged 60 years or older. Their numbers are expected to double by 2050. Key consumers of cardiovascular, diabetes and other chronic disease tests are found in this population segment.
Prevalence of chronic diseases
While the growing segment of older people is more vulnerable to chronic diseases such as diabetes, cardiovascular disease, and cancer, they negatively affect patients of all ages. Factors such as sedentary lifestyle, poor eating habits, smoking, and high alcohol consumption among large swaths of the population have contributed to the increase in these conditions.
Increase in the occurrence of infectious diseases
2019-nCov, HIV, Ebola, ZIKV, influenza virus, and other newly emerging infectious diseases have created a high disease burden worldwide. Early detection of infectious diseases can make the difference between life and death in many cases.
Influence of big tech innovators
Google, Apple, IBM, Dell, and other movers and shakers in information technology are finding ways to transform raw IVD data into actionable medical knowledge.
Acceptance of personalized care and desire for ease of use
A plethora of the development of handheld devices for IVD has been reported, particularly emphasizing on mobile diagnostics for use with saliva and sweat as analyses.
Fig.1 Large-scale trends that triggered innovations and expansion in IVD technologies.
IVD One-stop Solution
Creative Biolabs has a highly experienced team of scientists, project managers, and quality staff that have a long history of successful implementation of complex IVD development projects. By using a nimble cross-functional team approach, we partner with you to complete your IVD research project with speed and accuracy. Our services focus on advanced technology & hot area, gene detection/analysis, protein detection/analysis, diverse diagnostic platforms, and immunoassays.
Hot Technology & Research Area
Click to look for advanced technology-related IVD services in detail, including but not limited to: microfluidics, liquid biopsy, artificial Intelligence, liquid array……
Various Diagnostic Platform
Available diagnostic platforms include ELISA, ELISpot, CLIA, FIA, different lateral immunochromatographic assays and so forth.
Featured IVD Services
Creative Biolabs is professional in IVD antibody, antibody pair and antibody-based imaging tools development. Customized services are tailored to your needs.
More than 10 years' experience in IVD raw material development and project management
Extensive expertise in analytical methods, process development, and formulation chemistry.
Expertise lies in formulation chemistry, blood separation, and the semi- and quantitative determination of analyses in biological fluids.
Co-Development and commercialization of Point-of-Care Diagnostic Tests (POCT).
For Research Use Only.
Copyright © 2021 Creative Biolabs.